Welcome to the world of hyperbaric oxygen therapy

Helping AIDS, Cancer and MS with Oxygen
Part 3 of 6

Getting more oxygen invariably stimulates the appetite and the patients want to eat more, says Reillo. "Oxygen makes you hungry,' she says. With appetite improvement, Reillo counsels AIDS patients on the details of a well-balanced, nutritionally rich diet.

'The healthier you eat, the less likely you are to lose weight and develop infections," she states. Reillo cites another case of a patient who experienced rapid, much-needed weight gain after diving. Pierre, 42, stood six feet one inch, but weighed only 105 pounds. He was suffering from a body-wide dissemination of Mycobacterium which had begun to spread several months before he came to Reillo's clinic. Pierre was taking two conventional antibiotics to stem the spread of this opportunistic infection, and he continued with these drugs during hyperbaric oxygen treatment, says Reillo.

HBOT made rapid inroads on Plerre's infection and weight loss. He got into the chamber for 45 minutes three times weekly for a month, after which he had gained 30 pounds. Reillo notes that HBOT enables patients to remain on conventional drugs longer and with more safety because the oxygen helps detoxify the liver, which is continuously burdened with the toxic load from these drugs.

One of the most serious consequences of AIDS is the dangerously low level of immune cells called T lymphocytes, or T cells, but here again, HBOT is helpful, says Reillo. Over the course of four months of HBOT, Reillo was able to get a woman's T cells to climb from 400 to 800; even better, her CD4 count (another type of immune cell) doubled.

To a healthy person, this rise may seem modest, but declining T-cell counts is one of the hardest symptoms of AIDS to reverse, or even halt, Reillo notes. 'Rises like this can happen often if you start with the patient early after their diagnosis,' she adds.

HBOT can also provide relief from the severe dermatitis that often accompanies AIDS. The body of one male patient, 55, was 90% covered with dermatitis; oral and topical antifungal creams and prednisone brought no relief Yet after one week of HBOT (three treatments), the man experienced a decrease in the itching and irritation, says Reillo, and after two weeks, the skin on his arms and torso was free of dermatitis. Two months after starting oxygen therapy, all of his skin lesions had disappeared, and the condition did not reappear in the following months, Reillo adds.

Given these benefits, HBOT 'should be the standard of care instead of operating on the edges of medicine," says Reillo. Elsewhere in the world, HBOT is widely used for many disorders of blood circulation that arise as complications to major illnesses such as AIDS, she adds. In the U.S., there is still considerable resistance-fueled largely by the financial interests of conventional medicine-to the widespread use of HBOT for many conditions.

The cost savings of using HBOT adjunctively for AIDS treatment are pervasive. “HBOT is cost effective, saving between $50,000 and $75,000 annually when compared with only the current medical standard of care," Reillo states.

One of her patients saved $164,264 over the course of three and a half years; another patient's costs were only $12,615 a year on HBOT compared to the $89,518 he would have pal 'd had he received conventional care; a third patient saved $215,303 over the five years in which he was treated with HBOT.

Restoring Oxygen to Dying Tissues

Interest among physicians and patients in using oxygen therapy for an increasing range of conditions is growing, thanks to its "terrific side benefits,' states Trish Planck, director of The Hyperbaric Oxygen Clinic of Nevada, in Reno. Planck's clinic, like Reillo's, is also freestanding and independent of hospitals.

'We operate with the same standards and practices as HBOT delivered at a hospital, but we are not bound by the approved condition list, namely, what insurance companies are willing to reimburse," Planck says. If the patient can pay for it, Planck can provide it, she says, even if, according to conventional medicine, the application is "experimental."

One application frequently employed at Planck's clinic that is hardly experimental is the use of HBOT for repairing the extensive skin damage caused by radiation therapy for cancer. This widespread 'side effect' is called radionecrosis. A patient is given radiation for a cancer, whether on the skin or located internally, and the radiation beams are so toxic they seriously damage the skin and surrounding tissues; they turn black from lack of oxygen supply and begin to die (necrosis).

Skin damage due to radiation therapy is widespread and problematic. Bone necrosis (in the mouth, pelvis, sternum, clavicle, or thigh bone) resulting from radiation was reported as early as 1926. A ten-year study reported that the overall incidence of necrotic complications associated with head or neck tumors was 65.3% for 128 patients. A later study established that 235 of 378 patients (620/o) treated with radiation for cancer of the head or neck ended up with necrotic facial tissue.

This same study showed that when 206 of these patients underwent HBOT for the restoration of dying tissue, 720/o had an "excellent' result, 10% a "good" result, 150/o a "fair" response, and only 3% were 'judged failures. Actually, scientists have known about HBOT's ability to treat radiation damage since 1976, when at least 69 success cases were documented.

Many of Planck's HBOT radionecrosis patients are in the excellent category, she reports. One such patient, named Rene, had developed radionecrosis at 83 following radiation treatment for a head and neck cancer six years earlier. Soft tissue in his mouth was damaged in the course of radiation and several teeth died and had to be removed. Pain and infection developed in his lower jaw and failed to heal, and soon Rene whole mouth was necrotic, says Planck.

Not only was the tissue diseased, it was disfiguring his entire face. Here the utility of HBOT becomes apparent. Patients undergoing dental work (called debridement) for pain, infection, and necrosis of the mouth receive HBOT before and after the oral surgery, Planck explains. Typically, 20 to 30 treatments are required before surgery to oxygenate the tissue and reduce the infection. Following surgery, another 20 treatments are usually given to help the restored tissues heal.

Rene had 30 sessions in the hyperbaric chamber, after which his facial tissue showed signs of coming back to life, says Planck. Had he not undergone this therapy, it is probable that his skin infections would not have healed nor would the disfigurement have abated, despite surgery.

Following surgery, Rene had another 20 dives in the chamber. 'The tissues have healed up nicely and he's without pain," says Planck. 'Rene now getting fitted for new teeth.'

How does oxygen do its work? The oxygen appears to flood the damaged area and adjacent tissue with oxygen; this stimulates the tissue to revascularize-to repair damaged tiny blood vessels or to generate new ones. Then the body can recognize the radiated tissue as being a wound and apply energy and nutrients to its healing. Apparently, prior to this the oxygen-starved tissue is regarded by the body as if it were infact, dying, and best removed.

Another of Planck's patients, Linda, 40, developed dental infections and decay following radiation treatment for throat cancer. The radiation reduced the blood flow in her mouth and necrosis set in. The tissues in her mouth were black, says Planck The teeth she had left were dead. Linda's throat cancer had required the surgical removal of her I leaving her unable to speak. In addition, earlier breast cancer and surgery had left her night arm almost immobilized.

Linda arrived at Planck's clinic frail with a grayish pallor, and was initially afraid of getting into the sealed chamber. As her treatments proceeded, however, Linda came to look forward to the next dive.

Linda had 40 sessions in the hyperbaric chamber in preparation for restorative oral surgery, says Planck. Her improvements were considerable. 'She regained her natural skin color and her hair grew back As we restored blood circulation and oxygen supply to her mouth, she began to heal.'

Somewhere in the middle of the course of treatment, Linda regained mobility in her right arm, raising it above her head. A hip problem that prevented Linda from sleeping on that side improved after only three treatments. "In fact, her whole body gained in mobility such that physically she was a changed woman."

Planck’s clinical observations of the success of HBOT when used for radionecrosis leads her to the following recommendation: 'When patients have received high dosages of radiation, HBOT might be used early as a primitive measure for radiation necrosis that would otherwise develop."

Is Multiple Sclerosis a Oxygen Deficiency?

"Conventional medicine theorizes that multiple sclerosis is an autoimmune disorder caused by a microorganism (probably a virus) whose activity leads to the removal of the protective myelin sheath surrounding nerve fibers 'in the brain and spinal cord.

However, if you ask hyperbaric expert Richard A. Neubauer, M.D., director of Ocean Hyperbaric Center in Lauderdale-By the-Sea, Florida, the cause of multiple sclerosis (Ms) may be a lack of oxygen in the body's tissues. He's been proceeding on this hypothesis using pressurized oxygen for patients with multiple sclerosis. Dr. Neubauer proposed the oxygen deficiency cause based on the observed fact that providing MS patients with HBOT was successful in reducing symptoms of the disease. So he reasoned back wards to find a probable cause.

MS is a "wound or a disease of the blood vessels in the central nervous system," Dr. Neubauer contends in his new book, Hyperbaric Oxygen Therapy (with Morton Walker, Avery Publishing, 1997). A condition of chronic high blood pressure Within the brain and spinal cord damages blood vessels and leads to a lack of oxygen similar to that seen in cases of stroke. HBOT reoxygenates these oxygen-deprived tissues, he says.

The clinical evidence supports Dr.Neubauer's bold theory. In 1992, he summarized the existing clinical reports and estimated that about 12,000 MS patients in 14 countries had been treated for MS with HBOT. Of these, 70% had improvements in terms of bladder and bowel function and muscular spasticity. Very few patients who continued with HBOT had relapses or deteriorated any further.

At that time, on the basis of treating 1,500 MS patients over the course of 12 years, Dr. Neubauer declared that 'MS is sensitive to the dose of oxygen" but requires long-term therapy. The initial response may be an unreliable guide to the eventual outcome, he also cautioned, and concluded that, while HBOT is not a cure for MS, it is "the safest, most noninvasive, least expensive treatment devised to date." Another early study by Dr. Neubauer reported that of 250 MS patients treated with HBOT, 39% had a "dramatic"improvement 52% had "minimal to moderate" benefits, and only 90/o had no improvement.

Dr. Neubauer likens HBOT to insulin for diabetes: 'it provides a significant chance for control and stabilization of MS."

Documented benefits include a lessening of fatigue and pain, and improvements in balance, bladder control, vision, upper and lower limb mobility, coordination, and speech. Dr. Neubauer suggests that on the average, 20 HBOT sessions annually (I-2 per month) are enough to prevent a remission of MS. For best results, Dr. Neubauer recommends starting HBOT treatment as early as possible following the initial MS diagnosis. But even treating MS late in the game doesn't preclude positive results, as this brief case report shows.

Martha, 50, came to Dr. Neubauer's clinic in a battery powered cart. She could barely stand on her own and had been disabled for many years with MS. Shortly after her third hour of oxygen treatment, she announced her improvements. Martha said she felt 'absolutely wonderful" and called for her crutches. 'I got out of my cart and walked around and was astounded at my progress-it was happening that quickly."

Feature article from Alternative Medicine Magazine, Issue 23, May 1998

Click here to advance to the next page Part 4 of 6